Released Mar 15, 2012, during market hours
10-K filed Mar 15, 2012, 75 days after period end · 0001193125-12-116670
Q4 2011 · 10-K
Revenue$29.03M$29.03M no prior Q4 2010 on file+10.0% vs Q3 2011
Net Income$738.00K$738.00K no prior Q4 2010 on file+2,535.7% vs Q3 2011
EPS Diluted$0.02$0.02 no prior Q4 2010 on fileno prior Q3 2011 on file
Gross Profit$13,228,000—
Operating Income$1,388,000—
Operating Cash Flowderived$2,643,000−37.8%
Margins · derived
Gross margin45.6%
Operating margin4.8%
Net margin2.5%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|
| Revenue | $29.03M | — |
| Net Income | $738.00K | — |
| EPS Diluted | $0.02 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR